GRANTRYL

This brand name is authorized in South Africa

Active ingredients

The drug GRANTRYL contains one active pharmaceutical ingredient (API):

1 Granisetron UNII 318F6L70J8 - GRANISETRON HYDROCHLORIDE

Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. Read about Granisetron

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GRANTRYL Solution for injection	Health Products Regulatory Authority (ZA)	MPI, Generic
GRANTRYL Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AA02	Granisetron	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists
Discover more medicines within A04AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/5.7.2/0527, 43/5.7.2/0528, 44/5.7.2/0892, 44/5.7.2/0893